Table 3 Excluded full texts based on eligibility criteria
From: Medicines and vaccines supply chains challenges in Nigeria: a scoping review
SN | Authors | Title | Year | Reason |
|---|---|---|---|---|
1 | (Millar et al., 2014) | Patterns and predictors of malaria care-seeking, diagnostic testing, and artemisinin-based combination therapy for children under five with fever in Northern Nigeria: a cross-sectional study | 2014 | Irrelevant because it does not focus on medicine supply chain challenges |
2 | (Unger et al., 2014) | Treating diarrhoeal disease in children under five: the global picture | 2014 | Irrelevant because the full text does not capture study variables |
3 | (Mangham-jefferies et al., 2014) | What determines providers’ stated preference for the treatment of uncomplicated malaria? | 2014 | Irrelevant because the full text does not capture study variables |
4 | (Palafox, n.d.) | Mapping the private commercial sector distribution chain for antimalarials in six low-income countries in Africa and South East Asia | 2014 | Irrelevant because the full text does not capture study variables |
5 | (Obitte et al., 2009) | Survey of drug storage practice in homes, hospitals, and patent medicine stores in Nsukka, Nigeria | 2020 | Irrelevant because the full text does not capture study variables |
6 | Babalola, Stella and Lawan, Umar | Factors predicting BCG immunization status in northern Nigeria: a behavioral-ecological perspective | 2009 | Irrelevant because the full text does not capture study variables |
7 | Urban, Boris | Interventions to increase the distribution of vaccines in Sub-Saharan Africa: a scoping review | 2019 | Irrelevant because the full text does not capture study variables |
8 | (Karp et al., 2015) | Evaluating the value proposition for improving vaccine thermostability to increase vaccine impact in low and middle-income countries | 2018 | Irrelevant because the full text does not capture study variables |
9 | (Bassey et al., 2018) | The global switch from trivalent oral polio vaccine (tOPV) to bivalent oral polio vaccine (bOPV): facts, experiences and lessons learned from the south-south zone; Nigeria, April 2016 | 2018 | Irrelevant because the full text does not capture study variables |
10 | (Odume, 2020) | Taking tuberculosis preventive therapy implementation to national scale: the Nigerian PEPFAR Program experience | 2020 | Irrelevant because the full text does not capture study variables |
11 | (Griswold et al., 2018) | Evaluation of Treatment Coverage and Enhanced Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis in Five Local Government Areas Treating Twice Per Year in Edo State, Nigeria | 2018 | Irrelevant because the full text does not capture study variables |
12 | (Petersen et al., 2017) | Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab | 2017 | Irrelevant because the full text does not capture study variables |
13 | (Mangham-jefferies et al., 2015) | Mind the gap: knowledge and practice of providers treating uncomplicated malaria at public and mission health facilities, pharmacies and drug stores in Cameroon and Nigeria | 2015 | Irrelevant because the full text does not capture study variables |
14 | (Rao et al., 2017) | Immunization supply chains: Why they matter and how they are changing | 2017 | Irrelevant because the full text does not capture study variables |
15 | (Wright et al., 2017) | Improving iSC performance through outsourcing – Considerations for using third-party service providers to increase innovation, capacity, and efficiency | 2017 | Irrelevant because the full text does not capture study variables |
16 | (Ward & Kynvin, 2015) | Consumer-focused supply chains: a cross-case comparison of medicine appeal and acceptance in India, Uganda, and Nigeria | 2015 | Irrelevant because the full text does not capture study variables |
17 | (Molemodile et al., 2017) | Evaluation of a pilot intervention to redesign the decentralised vaccine supply chain system in Nigeria | 2017 | Irrelevant because the full text does not capture study variables |
|  | (Osadebe et al., 2017) | Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April – November 2015 | 2017 | Irrelevant because the full text does not capture study variables |
18 | (Hirsh Bar Gai et al., 2018) | Evaluating scenarios of locations and capacities for vaccine storage in Nigeria | Â | Irrelevant because the full text does not capture study variables |
19 | (Bangura et al., 2020) | Barriers to Childhood Immunization in Sub-Saharan Africa: A Systematic Review | 2020 | Irrelevant because the full text does not capture study variables |
20 | (Daniel & Oladapo, 2006) | Default from tuberculosis treatment programme in Sagamu, Nigeria Default from Tuberculosis Treatment Programme in Sagamu, Nigeria | 2006 | Irrelevant because the full text does not capture study variables |
21 | (Ikoh et al., 2009) | The influence of “Stock Out” on health-seeking behaviour of low-income women in Uyo urban, Akwa Ibom State, Nigeria | 2009 | Irrelevant because the full text does not capture study variables |
22 | (Aina et al., 2017) | Preliminary results from direct-to-facility vaccine deliveries in Kano, Nigeria | 2017 | Irrelevant because the full text does not capture study variables |
23 | (Tougher et al., 2009) | The private commercial sector distribution chain for antimalarial drugs in Benin Findings from a rapid survey | 2009 | Irrelevant because the full text does not capture study variables |
24 | (Brien et al., 2018) | Treat the Pain Program Megan | 2018 | Irrelevant because the full text does not capture study variables |
25 | (Monath et al., 2016) | Yellow fever vaccine supply: A possible solution | 2016 | Irrelevant because the full text does not capture study variables |
26 | (Sutter & Cochi, 2019) | Inactivated Poliovirus Vaccine Supply Shortage: Is There Light at the End of the Tunnel? | 2019 | Editorial comment |
27 | (Oleribe et al., 2017) | Individual and socioeconomic factors associated with childhood immunization coverage in Nigeria | 2017 | Irrelevant because the full text does not capture study variables |